North Carolina State University and The Hamner Institutes for Health Sciences have received a $1 million grant from the National Institute of Diabetes and Digestive and Kidney Disease to study why some patients have serious liver reactions to otherwise safe drugs. The money is part of the Challenge Grant Program supported by federal stimulus dollars. Dr. David Threadgill, professor and head of the Department of Genetics at NC State, and Dr. Paul Watkins, founding director of The Hamner-UNC Institute for Drug Safety Sciences, are the lead investigators.
Link: http://news.ncsu.edu/releases/mkthreadgillgrant/